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Abstract
Background:  The homeodomain containing transcription factor Nkx2.2 is essential for the
differentiation of pancreatic endocrine cells. Deletion of Nkx2.2 in mice leads to misspecification
of islet cell types; insulin-expressing β cells and glucagon-expressing α cells are replaced by ghrelin-
expressing cells. Additional studies have suggested that Nkx2.2 functions both as a transcriptional
repressor and activator to regulate islet cell formation and function. To identify genes that are
potentially regulated by Nkx2.2 during the major wave of endocrine and exocrine cell
differentiation, we assessed gene expression changes that occur in the absence of Nkx2.2 at the
onset of the secondary transition in the developing pancreas.
Results: Microarray analysis identified 80 genes that were differentially expressed in e12.5 and/or
e13.5 Nkx2.2-/- embryos. Some of these genes encode transcription factors that have been
previously identified in the pancreas, clarifying the position of Nkx2.2 within the islet transcriptional
regulatory pathway. We also identified signaling factors and transmembrane proteins that function
downstream of Nkx2.2, including several that have not previously been described in the pancreas.
Interestingly, a number of known exocrine genes are also misexpressed in the Nkx2.2-/- pancreas.
Conclusions: Expression profiling of Nkx2.2-/- mice during embryogenesis has allowed us to
identify known and novel pancreatic genes that function downstream of Nkx2.2 to regulate
pancreas development. Several of the newly identified signaling factors and transmembrane
proteins may function to influence islet cell fate decisions. These studies have also revealed a novel
function for Nkx2.2 in maintaining appropriate exocrine gene expression. Most importantly,
Nkx2.2 appears to function within a complex regulatory loop with Ngn3 at a key endocrine
differentiation step.
Background
The pancreas is a multifunctional organ that is critical for
maintaining glucose homeostasis and for producing
many of the enzymes required for digestion of carbohy-
drates, lipids and proteins. To carry out these diverse func-
tions, the pancreas contains three major tissue types: the
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exocrine acinar cells, the endocrine cells that comprise the
islet of Langerhans, and the ductal epithelial cells.
Although each of these pancreatic components performs
unique functions, all are derived from a defined set of
endodermally-derived progenitors [1]. Subsequent pan-
creatic morphogenesis and differentiation of these pro-
genitor populations is dependent on the concerted action
of multiple transcriptional regulators. Early during pan-
creatic bud evagination, Pancreatic duodenal homeobox
1 (Pdx1) and Pancreatic transcription factor 1a (Ptf1a) are
co-expressed in the pancreatic progenitor population
[1,2]. Ptf1a, a basic helix-loop-helix (bHLH) transcription
factor, becomes restricted to the exocrine cell population,
where it is essential for exocrine cell formation and func-
tion [2,3]. Pdx1 expression is maintained throughout the
early pancreatic epithelium and becomes mostly restricted
to β and δ cells after the secondary transition, although
low levels of Pdx1 persist in some acinar cells into adult-
hood [4-6]. Pdx1 has distinct functions at each develop-
mental stage and in each of the cell types where it is
expressed, and itself is critically dependent on the winged
helix transcription factors Foxa1 and Foxa2 [7-9]. Ngn3, a
bHLH transcription factor, is required downstream of
Pdx1 to activate the endocrine differentiation program
[10-13]. Further islet cell fate determination in the Ngn3+
cells then depends on a number of additional transcrip-
tion factors including Pdx1, Nkx2.2, Pax4, Pax6, Isl1,
NeuroD1, Arx, and Nkx6.1, each of which has been iden-
tified and characterized through genetic deletion or over-
expression studies [14-19]. These and other transcription
factors are then necessary for appropriate neogenesis, dif-
ferentiation, and maturation of the five islet cell types
(recently reviewed in [5,20-22]).
Although much is known about the identity, expression
and function of many of the intrinsic regulatory proteins
involved in pancreatic development and differentiation,
the identification of downstream targets of these tran-
scription factors to mediate these developmental events
has proven to be more challenging. In efforts to identify
downstream functional players during pancreagenesis,
multiple groups have determined pancreatic gene expres-
sion profiles of wild type and transcription factor knock-
out models, including Pdx1, Ngn3, NeuroD1, and FoxA2
[23-30]. Alternatively, temporal comparisons between
transcription factor positive cell populations, such as
Pdx1+ or Ngn3+ [31,32], by microarray analysis have also
uncovered important downstream factors. Here we
present the first study comparing gene expression altera-
tions between wild type and Nkx2.2-/- mouse pancreata at
e12.5 and e13.5, the stages marking the onset of the sec-
ondary transition when the major wave of islet cell type
specification events occur for both endocrine and exo-
crine pancreas.
Nkx2.2 is a homeodomain containing transcription factor
critical for endocrine pancreas specification [19]. Prior to
e15.5, the pancreas of Nkx2.2-/- mice appears overtly nor-
mal and contains wild type numbers of undifferentiated
Pdx1+ pancreatic epithelium and Ngn3+ endocrine pro-
genitor cells [12,19,33]. As development proceeds, the
Nkx2.2-/- mice form the normal numbers of total endo-
crine and exocrine cells; however, within the endocrine
compartment all β cells, most α cells and a subset of PP
cells fail to differentiate and are replaced by a ghrelin-pro-
ducing cell population, which persists to comprise the
majority of a misshapen islet. Nkx2.2-/- mice die within
days after birth with severe hyperglycemia [19,34]. Nkx2.2
expression is initiated at e8.75 in the dorsal pancreas and
e9.5 in the ventral pancreas, shortly after the activation of
Pdx1 in each anlage [5]. High level Nkx2.2 expression
subsequently becomes restricted to the centralized epithe-
lium at e11.5, where it is upregulated in a large number of
the Ngn3+ endocrine progenitor cells [5,12]. Cells express-
ing low levels of Nkx2.2 are also apparent throughout the
undifferentiated pancreatic epithelial population until
after the secondary transition [5]. Multiple in vitro and in
vivo studies suggest that Nkx2.2 mediates early islet cell
fate decisions by functioning both as a transcriptional
repressor and activator, depending on temporal and cellu-
lar context [35-39]. To date, however, MafA and insulin
(Ins2) are the only two verified direct targets identified
downstream of Nkx2.2 in the pancreas [35,38]. MafA and
Ins2 both represent mature β cell genes; the molecular
mechanisms by which Nkx2.2 controls early endocrine
specification remain largely unknown. In an effort to
identify downstream direct and indirect targets of Nkx2.2
that promote or inhibit appropriate islet cell differentia-
tion, we performed microarray analyses at e12.5 and
e13.5 during pancreas development. This analysis has
resulted in the identification and characterization of
expression differences for several known and previously
uncharacterized pancreatic genes. These studies clarify the
position of Nkx2.2 within the known transcription factor
network that regulates islet specification. Furthermore, we
have identified a novel role for Nkx2.2 in the regulation of
several exocrine-specific genes, suggesting that Nkx2.2
may also function to influence gene expression in the
early Pdx1+ Ptf1a+ pancreatic progenitor cell.
Results and Discussion
Gene expression differences between wild type and 
Nkx2.2-/- pancreata
To identify genes that function downstream of Nkx2.2
during early pancreas development, we compared gene
expression profiles of e12.5 or e13.5 wild type and
Nkx2.2-/- pancreata. We restricted our analysis to the onset
of the secondary transition, when the principal wave of
endocrine differentiation begins, to enrich for down-BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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stream direct and indirect targets of Nkx2.2 that are
involved in the early events of islet cell type specification.
Global gene profiling at these time points also allowed us
to minimize gene expression differences caused by the
islet cell type conversions that occur later in the Nkx2.2-/-
mice. In addition, between e12.5 and e13.5, Nkx2.2 is
expressed broadly throughout the undifferentiated pan-
creatic epithelium, which is present in comparable
amounts between wild type and Nkx2.2-/-  pancreata
(Additional File 1: Figure S1 and data not shown; [33]).
This allows for the enrichment of equal quantities of wild
type and mutant tissue that would normally contain a
high percentage of Nkx2.2-expressing cells.
Pools of cDNA generated from e12.5 and e13.5 pancreata
(n = 5 per stage, per genotype) were amplified, labeled
and hybridized to PancChip 6.1 (UPenn) microarrays
containing 13,059 mouse cDNAs [32]. Both statistical sig-
nificance (<20% FDR) and a fold change threshold of 1.5
were used to select genes for further verification and anal-
ysis. At e12.5, 65 genes were differentially expressed, of
which 49 were downregulated and 16 upregulated in
Nkx2.2-/- pancreata compared to wild type (Table 1 and
2). By e13.5, an additional 15 genes were downregulated,
which may begin to reflect the differences in islet cell type
populations between wild type and Nkx2.2-/- mice and/or
may be due to the identification of additional direct or
secondary downstream Nkx2.2 targets (Table 3). We used
gene ontology (GO) terms to categorize the protein prod-
ucts of genes misregulated in the Nkx2.2-/- pancreas (Table
1, 2, and 3, Figure 1A, B). Many of the genes encode pro-
teins not previously identified in the pancreas, as well as
known pancreatic factors. As expected, we saw a large
decrease in Nkx2.2 expression, as well as significant
changes in the expression of glucagon, insulin and ghrelin
(Table 1, 2, and 3). As further validation of the experimen-
tal approach and microarray platform, we used quantita-
tive real-time PCR to verify many of the altered genes that
represented several classes of proteins. Of those tested,
77.8% displayed expression changes that corresponded
well with the microarray analysis (Figure 1C), closely
reflecting the 20% FDR used as a statistical cutoff. Below
we discuss the further characterization of a select subset of
genes with altered expression using quantitative real-time
PCR (qRTPCR) to compare their gene expression levels
and mRNA in situ analysis to compare their spatial locali-
zation in wild type versus Nkx2.2-/- pancreata.
Altered expression of genes encoding transcription factors
Interestingly, a relatively large proportion (20%) of down-
regulated genes in the Nkx2.2-/- pancreas are transcription
factors (Table 1, 3, Figure 1A), whereas no transcription
factors were found to be significantly upregulated (Table
2). Six of the nine transcription factors were confirmed by
quantitative rt-PCR (qRTPCR) (Figure 1C); expression of
irx3, hes7 and irf6 did not appear to be changed in the
Nkx2.2-/- pancreas at e12.5, e15.5, or e18.5 (Figure 1C and
data not shown). Of the genes with altered expression, it
appears that several encode transcription factors that are
critical during early islet cell fate specification, including
Ngn3, Myt1, NeuroD1, and MafB.
Ngn3 is a basic helix-loop-helix transcription factor that is
essential for the formation of the endocrine islet cell pop-
ulation [10]. Ngn3 expression defines the endocrine pro-
genitor cell and several knockout and lineage tracing
studies have determined that Ngn3 is required for the
specification of all five endocrine cell types [10,11,31].
Nkx2.2 and Ngn3 are co-expressed in the endocrine pro-
genitor cell and in the absence of Ngn3, Nkx2.2 expres-
sion in these cells is lost [5]. In the absence of Nkx2.2,
Ngn3+ cell numbers remain unchanged (Figure 2B and
2C; [12]), but there appears to be a significant and sus-
tained reduction of Ngn3 expression (Figure 2A). These
combined results suggest that Ngn3 and Nkx2.2 function
in a co-regulatory loop, and maintenance of their respec-
tive expression levels within the progenitor cell may be
necessary to specify appropriate islet cell fates. Not sur-
prisingly, Myelin transcription factor 1 (Myt1), a down-
stream target of Ngn3 [40], is significantly reduced in the
Nkx2.2-/- mice. Myt1 has also been shown to be important
for appropriate endocrine pancreas differentiation and, at
e13.5, over 60% of Ngn3+ cells also express Myt1 [41].
Furthermore, Myt1 and Ngn3 are believed to form a feed-
forward loop to promote endocrine differentiation [40]. A
significant reduction of Myt1 expression in the Nkx2.2-/-
mice is not apparent until e13.5, which may suggest that
its down-regulation is secondary to the loss of Ngn3. qRT-
PCR analysis confirmed that Myt1 expression becomes
decreased at e13.5 and the reduction in expression is
maintained throughout gestation (Figure 2E). RNA in situ
hybridization analysis at e14.5 and e17.5 further verified
decreased Myt1 expression throughout the pancreatic epi-
thelium (Figure 2F, G, H, and 2I). In summary, our data
suggest that Nkx2.2 functions within the Myt1 and Ngn3
regulatory loop. Future studies will elaborate the precise
regulatory connections between these three factors to
specify appropriate islet cell fate decisions.
NeuroD1 is a basic helix-loop-helix transcription factor
that has also been shown to function directly downstream
of Ngn3. Consistent with the reduction of Ngn3 expres-
sion, NeuroD1 is downregulated in the Nkx2.2-/- mice
(Figure 2D; [42]). Furthermore, we have recently deter-
mined that Nkx2.2 and Ngn3 cooperate to directly acti-
vate the NeuroD1 promoter [43], suggesting that the
reduction of NeuroD1 expression could be caused by both
direct and indirect regulation. Previous experiments also
indicate that Nkx2.2 and NeuroD1 genetically interact in
the alpha cell population [42]. It is likely that these com-BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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Table 1: Downregulated genes in Nkx2.2-/- versus Nkx2.2+/+ pancreata at e12.5.
Genbank Accession Number Gene Symbol Gene Name e12.5
Fold Change
Secreted Factors
NM_008100 Gcg GLUCAGON -20.0
NM_145435 Pyy PEPTIDE YY -7.6
NM_007694 Chgb CHROMOGRANIN B -2.0
NM_009242 Sparc SECRETED ACIDIC CYSTEINE RICH GLYCOPROTEIN -1.9
NM_009258 Spink3 SERINE PEPTIDASE INHIBITOR, KAZAL TYPE 3 -1.8
NM_010257 Gast GASTRIN -1.7
NM_008343 Igfbp3 INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 -1.6
NM_008386 Ins1 INSULIN I -1.5
Transcription Factors
NM_010919 Nkx2-2 NK2 TRANSCRIPTION FACTOR RELATED, LOCUS 2 (DROSOPHILA) -5.0
NM_009719 Neurog3 NEUROGENIN 3 -2.7
NM_025824 Bzw1 BASIC LEUCINE ZIPPER AND W2 DOMAINS 1 -1.9
NM_010894 Neurod1 NEUROGENIC DIFFERENTIATION 1 -1.9
NM_033041 Hes7 HAIRY AND ENHANCER OF SPLIT 7 (DROSOPHILA) -1.8
NM_008092 Gata4 GATA BINDING PROTEIN 4 -1.7
NM_178083 Irf6 INTERFERON REGULATORY FACTOR 6 V-MAF 
MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE
-1.6
NM_010658 Mafb FAMILY, PROTEIN B (AVIAN) -1.6
NM_019738 Nupr1 NUCLEAR PROTEIN 1 -1.6
Transmembrane Proteins
NM_020626 Tmem27 TRANSMEMBRANE PROTEIN 27 -4.5
NM_011695 Vdac2 VOLTAGE-DEPENDENT ANION CHANNEL 2 -2.8
NM_011150 Lgals3bp LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN -1.6
NM_144926 Sez6l2 SEIZURE RELATED 6 HOMOLOG LIKE 2 -1.6
Transporters
NM_013697 Ttr TRANSTHYRETIN -3.6
NM_172479 Slc38a5 SOLUTE CARRIER FAMILY 38, MEMBER 5 -3.2
NM_007618 Serpina6 SERINE (OR CYSTEINE) PEPTIDASE INHIBITOR, CLADE A, MEMBER 6 -1.7
NM_007423 Afp ALPHA FETOPROTEIN -1.6
NM_007443 Ambp ALPHA 1 MICROGLOBULIN/BIKUNIN -1.6
Peptidases
NM_008792 Pcsk2 PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 2 -2.2
NM_025583 Ctrb1 CHYMOTRYPSINOGEN B1 -1.8
NM_001024698 Cpa2 SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR -1.7
NM_011909 Usp18 UBIQUITIN SPECIFIC PEPTIDASE 18 -1.6
NM_013494 Cpe CARBOXYPEPTIDASE E -1.6
NM_146101 Habp2 HYALURONIC ACID BINDING PROTEIN 2 -1.6
Signaling
NM_021356 Gab1 GROWTH FACTOR RECEPTOR BOUND PROTEIN 2-ASSOCIATED 
PROTEIN 1
-2.5
NM_145736 Pim2 PROVIRAL INTEGRATION SITE 2 -1.7
NM_009245 Serpina1c SERINE (OR CYSTEINE) PEPTIDASE INHIBITOR, CLADE A, MEMBER 
1A
-1.6
NM_008052 Dtx1 DELTEX 1 HOMOLOG (DROSOPHILA) -1.5
Metabolism
NM_018874 Pnliprp1 PANCREATIC LIPASE RELATED PROTEIN 1 -2.5
NM_001081070 Pdia2 PROTEIN DISULFIDE ISOMERASE ASSOCIATED 2 -2.1
NM_009040 Rdh16 RETINOL DEHYDROGENASE 16 -1.5
Translation
NM_008774 Pabpc1 POLY A BINDING PROTEIN, CYTOPLASMIC 1 -1.5BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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plex regulatory and functional interactions between
Nkx2.2, Ngn3, Myt1 and NeuroD1 are necessary to pre-
cisely control early islet cell fate decisions.
We also detected a significant reduction in MafB expres-
sion. Two members of the large Maf transcription factor
family, MafA and MafB, are important for endocrine pan-
creas development [44-49]. MafA, a mature β cell marker,
is a direct transcriptional target of Nkx2.2 and its expres-
sion is absent in Nkx2.2-/- mice [38]. In this study, the
comparative gene expression analysis was performed at a
time point prior to MafA expression in the pancreas (MafA
signal was undetectable in both wild type and mutant
pancreatic e12.5 and e13.5 samples) and therefore MafA
was not included on our list of downregulated genes.
MafB is expressed prior to MafA and is critical for appro-
Other
CV676831 9330162012Rik CDNA RIKEN 9330162012 GENE -3.3
CF585856 IMAGE = 6430431 Unknown -3.3
NM_026791 Fbxw9 F-BOX AND WD-40 DOMAIN PROTEIN 9 -2.8
CF582515 IMAGE = 6432606 Unknown -2.6
NM_026479 Zcchc10 ZINC FINGER, CCHC DOMAIN CONTAINING 10 -2.0
NM_010058 Dmwd DYSTROPHIA MYOTONICA-CONTAINING WD REPEAT MOTIF -1.9
NM_134013 Psme4 PROTEASOME (PROSOME, MACROPAIN) ACTIVATOR SUBUNIT 4 -1.6
NM_198000 1700001O22Rik RIKEN CDNA 1700001O22 GENE -1.6
NM_025946 2010100O12Rik RIKEN CDNA 2010100O12 GENE -1.6
49 genes were downregulated in Nkx2.2-/- pancreata at e12.5 when compared to wild type. Genes were identified using PancChip 6.1 microarray 
analysis. Statistical significance of 20% FDR and a fold change of 1.5 were used as cutoffs for determining expression changes. Genes were 
categorized based on function determined by gene ontology (GO) term associations.
Table 1: Downregulated genes in Nkx2.2-/- versus Nkx2.2+/+ pancreata at e12.5. (Continued)
Table 2: Upregulated genes in Nkx2.2-/- versus Nkx2.2+/+ pancreata at e12.5 and e13.5.
Genbank Accession Number Gene Symbol Gene Name e12.5
Fold Change
Secreted Factors
NM_021488 Ghrl GHRELIN 6.5
NM_010491 Iapp ISLET AMYLOID POLYPEPTIDE 5.2
NM_025684 Nepn RIKEN CDNA 5730521E12 GENE 3.1
Transmembrane Proteins
NM_145539 Tm4sf4 TRANSMEMBRANE 4 SUPERFAMILY MEMBER 4 4.5
NM_021286 Sez6 SEIZURE RELATED GENE 6 2.4
NM_030701 Gpr109a G PROTEIN-COUPLED RECEPTOR 109A 1.9
NM_008150 Gpc4 GLYPICAN 4 1.8
NM_007417 Adra2a ADRENERGIC RECEPTOR, ALPHA 2A 1.7
Peptidases
NM_033612 Ela1 ELASTASE 1, PANCREATIC 1.9
Metabolism
NM_011107 Pla2g1b PHOSPHOLIPASE A2, GROUP IB, PANCREAS 2.7
NM_007981 Acsl1 ACYL-COA SYNTHETASE LONG-CHAIN FAMILY MEMBER 1 2.0
NM_007482 Arg1 ARGINASE 1, LIVER 1.8
Chromatin
NM_011417 Smarca4 SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT 
REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4
3.6
Other
CV677510 IMAGE = 6437263 Unknown 1.8
NM_145616 Lrrc49 LEUCINE RICH REPEAT CONTAINING 49 1.7
NM_173405 6530401C20Rik RIKEN CDNA 6530401C20 GENE 1.7
16 genes were upregulated in Nkx2.2-/- pancreata at e12.5 and e13.5. Genes were identified using PancChip 6.1 microarray analysis and a fold 
change of 1.5 was used as a cutoff for determining expression changes. Genes were categorized based on function determined by gene ontology 
(GO) term associations.BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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priate differentiation of α and β cells [46,50]. Here we
demonstrate that MafB expression is decreased in Nkx2.2-
/- mice at e12.5 (Table 1). Further verification by qRTPCR
confirmed that decreased expression of MafB was main-
tained throughout gestation, with the largest observed dif-
ferences occurring at e15.5 (Figure 2J, L, and 2P).
Although it is possible that the reduction in MafB expres-
sion is due to the loss of α and β cells, as shown by a
reduction of MafB+ cells at e12.5 (Figure 2K and 2O),
MafB  in situ hybridization analysis suggests that MafB
expression is also reduced on a per cell basis throughout
the pancreatic epithelium (Figure 2N and 2R). We have
also determined that Nkx2.2 binds directly to a highly
conserved DNA sequence within the MafB 5' upstream
regulatory region (Torres and Sussel, unpublished data),
suggesting that Nkx2.2 may regulate both MafA and MafB
to impact the early specification of α and β cells in addi-
tion to their proper maturation state.
Isl1 and Etv1 (ER81) show differential expression by
e13.5 in the Nkx2.2-/- mice (Table 3). Isl1 is necessary for
dorsal pancreatic mesenchyme and endocrine cell differ-
entiation [51]. Etv1, an Ets domain family member, is
expressed in the pancreas [52,53]; however, its function
during pancreas organogenesis remains unknown. Etv1 is
important in neuronal differentiation and neurogenesis
[54,55] and has recently been shown to form a transcrip-
tional complex with Sox9, a characterized pancreatic pro-
genitor marker, in breast cancer cells [56-58].
Interestingly, Isl1, and Etv1 appear to be shared down-
stream (indirect or direct) targets of Nkx2.2 and Ngn3
(Additional File 2: Table S1). The complex regulatory rela-
tionship between Nkx2.2 and Ngn3 suggests that these
factors function in the same pathway or in parallel to reg-
ulate Isl1 and Etv1. Further elucidation of the co-regula-
tory pathways and intricate feedback mechanisms that we
have uncovered in these studies will facilitate our under-
Table 3: Downregulated genes in Nkx2.2-/- versus Nkx2.2+/+ pancreata at e12.5.
Genbank Accession Number Gene Symbol Gene Name e13.5
Fold Change
Secreted Factors
NM_008387 Ins2 INSULIN II -3.4
NM_170593 Disp2 DISPATCHED HOMOLOG 2 (DROSOPHILA) -1.8
NM_009523 Wnt4 WINGLESS-RELATED MMTV INTEGRATION SITE 4 -1.6
Transcription Factors
NM_008393 Irx3 IROQUOIS RELATED HOMEOBOX 3 (DROSOPHILA) -2.6
NM_008665 Myt1 MYELIN TRANSCRIPTION FACTOR 1 -2.4
NM_007960 Etv1 ETS VARIANT GENE 1 -1.8
NM_021459 Isl1 ISLET-1 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN -1.5
Transmembrane Proteins
NM_001014761 Scn2b SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, BETA -2.0
NM_024226 Rtn4 RETICULON 4 -1.9
Transporters
NM_007514 Slc7a2 SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, 
Y+ SYSTEM), MEMBER 2
-2.1
NM_028924 Mtac2d1 MEMBRANE TARGETING (TANDEM) C2 DOMAIN CONTAINING 1 -1.6
Signaling
NM_007832 Dck DEOXYCYTIDINE KINASE -2.3
Metabolism
NM_007748 Cox6a1 CYTOCHROME C OXIDASE, SUBUNIT VI A, POLYPEPTIDE 1 -2.0
Chromatin
NM_175074 Hmgn3 HIGH MOBILITY GROUP NUCLEOSOMAL BINDING DOMAIN 3 -1.7
Other
NM_152800 Tor2a TORSIN FAMILY 2, MEMBER A -2.4
15 additional genes were downregulated in Nkx2.2-/- pancreata at e13.5. Genes were identified using PancChip 6.1 microarray analysis and a fold 
change of 1.5 was used as a cutoff for determining expression changes. Genes were categorized based on function determined by gene ontology 
(GO) term associations.BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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standing of elaborate transcriptional networks that regu-
late islet cell fate decisions.
Altered expression of genes encoding transmembrane and 
secreted factors
Two particularly interesting classes of genes that displayed
altered regulation in the Nkx2.2-/- pancreas are transmem-
brane proteins (9.3% downregulated and 31% upregu-
lated; Figure 1A and 1B) and secreted factors (17%
downregulated and 19% upregulated; Figure 1A and 1B).
These classes of proteins are particularly interesting
because they have the potential to interface with environ-
mental and extracellular signals to direct cellular function.
To determine whether these gene alterations were due to
the loss or gain of specific cell types, or due to aberrant
ectopic expression, we analyzed gene expression changes
over the course of embryonic development and per-
formed mRNA in situ analysis to define their spatial local-
ization within the pancreas.
The transmembrane protein Tmem27, also known as col-
lectrin, is expressed in multiple endocrine cell types dur-
ing development, including α and β cells, but becomes
restricted to β cells in the adult where it functions to
Categorization and confirmation of Nkx2.2-/- gene expression changes Figure 1
Categorization and confirmation of Nkx2.2-/- gene expression changes. (A, B) Gene changes categorized by gene 
ontology (GO) terms determined in Tables 1, 2, and 3. Quantification of downregulated (A) and upregulated (B) genes is rep-
resented as percentages when compared to total affected genes. (C) qRTPCR verification of genes of interest at e13.5. Genes 
are listed in alphabetical order, except Tm4sf4, which was graphed separately due to a larger y-axis data range. Error bars rep-
resent SEM and asterisks denotes statistical significance < 0.05. Wild type = grey bars, Nkx2.2-/- = black bars.BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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Loss of Nkx2.2 affects expression of critical early endocrine progenitor transcription factors; Ngn3, NeuroD1, Myt1, and MafB Figure 2
Loss of Nkx2.2 affects expression of critical early endocrine progenitor transcription factors; Ngn3, NeuroD1, 
Myt1, and MafB. qRTPCR of (A) Ngn3 levels were assessed at e12.5, e13.5, and e15.5; (D) NeuroD1, (E) Myt1, and (J) MafB 
transcript levels were determined at e13.5, e15.5, and e18.5 and all genes compared wild type (grey bars) and Nkx2.2-/- pancre-
ata (black bars). In situ hybridization comparing wild type and Nkx2.2-/- pancreas at e15.5 of Ngn3 (B and C), at e14.5 and e17.5 
of Myt1 (F, G, H, and I), at e15.5 and e17.5 of MafB (L, N, P, and R). Immunofluorescence staining of MafB (green) was com-
pared between wild type (K) and Nkx2.2 null (O) pancreata at e12.5. Immunofluorescence staining of Ela1 (green) on adjacent 
sections at e15.5 shows restriction to the endocrine compartment (M and Q). DAPI (blue) represents nuclei. Error bars repre-
sent SEM and asterisks denote statistical significance < 0.05. Magnification 20× for all except N and R, which are 40×. Large 
dashed lines outline the pancreas at e12.5, e14.5 and e15.5. Small dashed lines outline MafB expression.BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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increase β cell proliferation in vivo [59]. Tmem27 expres-
sion is increased in hypertrophied islets and has been
shown to function in β cell lines and primary β cells to
enhance glucose stimulated insulin secretion [60]. How-
ever, in vivo loss of Tmem27 did not affect overall islet
number, β cell mass, or function; islet composition was
not assessed in this study [61]. As would be expected of a
factor that is expressed in α and β cells during develop-
ment, Tmem27 is significantly reduced in e12.5 and e13.5
Nkx2.2-/- mice, which have less α cells and completely lack
β cells (Table 1). Unexpectedly, however, by late gestation
Tmem27 transcript is expressed at equivalent levels
throughout the endocrine compartment in wild type and
Nkx2.2-/- pancreas, as measured both by qRTPCR (Figure
3A) and RNA in situ hybridization analysis (Figure 3B, C,
and 3D and 3G, H, and 3I). Furthermore, immunofluo-
rescence staining of Tmem27 and ghrelin on adjacent sec-
tions of e17.5 wild type and Nkx2.2-/- pancreas (Figure 3E,
F, J, and 3K) confirm that some ghrelin cells normally co-
express Tmem27 and this expression is maintained in the
Nkx2.2-/-  ghrelin-expressing population. Therefore, the
early reduction in Tmem27 expression in the Nkx2.2-/-
pancreas could be attributed to the absence of the α and β
cell populations, and the restoration of normal Tmem27
expression levels could be due to its expression in the
ghrelin cell population that has now replaced the missing
islet cell types. However, this does not account for the loss
of Tmem27 expression during midgestation (e13.5 e15.5)
when the replacement ghrelin cells have already formed.
This would suggest that there is a transient reduction or
loss of Tmem27 expression in mutant pancreas during the
secondary transition that may contribute to, or be caused
by, the cell fate switch that is occurring in the Nkx2.2-/-
pancreas.
In contrast to Tmem27, Adra2a, a G-protein coupled
receptor, has increased expression early in Nkx2.2-/- pan-
creas development, but becomes decreased in late Nkx2.2-
/-  pancreas (Table 2, Figure 3L). Adra2a is normally
expressed in pancreatic islets [62,63] where it functions as
a β cell postsynaptic receptor to inhibit insulin secretion
[64,65]. The loss of Adra2a expression late in gestation is
consistent with the absence of β cells. However, the ele-
vated expression of Adra2a in the Nkx2.2-/-  pancreas
between e12.5 - e14.5 (Table 2, Figure 3L, M, and 3N) sug-
gests that Adra2a might also be expressed in non-β cell
populations prior to β cell formation. The early Adra2a
gene expression changes that occur in response to loss of
Nkx2.2 activity may be indicative of a functional role for
Adra2a outside of the β cell.
One of the most highly upregulated genes identified in
the Nkx2.2-/-  pancreas by the microarray analysis is
Tm4sf4, a member of the L6 domain superfamily of tet-
raspanin surface proteins [66]. Tm4sf4 is expressed in
non-dividing hepatocytes [67] and the human ortho-
logue, il-TMP, is found in non-dividing intestinal epithe-
lial cells [68]. Expression of Tm4sf4 in the pancreas has
not been previously reported. Our analysis shows that in
wild type pancreas, Tm4sf4 is normally expressed at low
levels throughout the pancreatic epithelium at all stages
examined (Figure 3O, P, Q, and 3R). Furthermore,
Tm4sf4 is enriched in FACs-purified Ngn3-EGFP cells
(Balderes and Sussel, unpublished data; [13]) and is
upregulated in pancreata that have undergone exocrine to
endocrine reprogramming [69]. In the Nkx2.2-/- pancreas,
qRTPCR and mRNA in situ analysis demonstrated that
Tm4sf4 expression is increased in the pancreas through-
out gestation (Table 2, Figure 3O, P, Q, and 3R and 3U, V,
and 3W). At early stages of pancreas specification, Tm4sf4
appears to be broadly expressed throughout the Nkx2.2-/-
pancreatic epithelium (Figure 3P, Q, U, and 3V), but
beginning at e15.5, Tm4sf4 mRNA becomes restricted to
the ductal and endocrine compartment in the Nkx2.2-/-
pancreata (Figure 3R, W, and data not shown). Interest-
ingly, at e14.5 we observed a subpopulation of Tm4sf4+
cells in Nkx2.2-/-  pancreata that appear to express
extremely high levels of Tm4sf4 within the ductal epithe-
lium (Figure 3Q and 3V). Antibodies against Tm4sf4 are
not available to precisely determine cell type localization;
however, analysis of Tm4sf4 mRNA and ghrelin protein
expression on adjacent sections demonstrates that Tm4sf4
is restricted to the ductal and endocrine compartments,
and partially co-localizes with the ghrelin population in
the e17.5 Nkx2.2-/- pancreas (Figure 3R, S, W, X, and 3Y).
Future studies will focus on pancreatic cell type expression
and subcellular localization of Tm4sf4. Closely-related
Tm4sf4 family members and other tetraspanins are
known to interact with integrins, and are often involved in
EMT, cell adhesion mechanisms and/or migration events
[70-73]. Since Tm4sf4 appears to be enriched in the
Ngn3+ cell population and is one of the most highly
upregulated genes in the Nkx2.2-/- pancreata, we speculate
that the aberrant upregulation of Tm4sf4 in the endocrine
progenitor cells of the Nkx2.2-/- mice may interfere with
normal cell-cell interactions and/or the interpretation of
extrinsic signals to prevent appropriate islet cell differenti-
ation. Furthermore, the Tm4sf4 gene contains two highly
conserved Nkx2.2 binding sites (data not shown), sug-
gesting that Tm4sf4 might function directly downstream
of Nkx2.2 in the progenitor population to modulate islet
cell fate choice.
Altered expression of exocrine genes
Surprisingly, although we had not previously detected a
change in exocrine cell numbers, several genes expressed
in the exocrine compartment also display altered expres-
sion in the Nkx2.2-/- pancreas. The Nkx2.2-/- mice do not
display overt exocrine pancreatic defects [19,34]; how-
ever, Nkx2.2 is initially co-expressed with Pdx1 and Ptf1aBMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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Loss of Nkx2.2 affects expression of known endocrine transmembrane proteins, Tmem27, Adra2a, and a novel tetraspanin,  Tm4sf4 Figure 3
Loss of Nkx2.2 affects expression of known endocrine transmembrane proteins, Tmem27, Adra2a, and a novel 
tetraspanin, Tm4sf4. qRTPCR of (A) Tmem27, (L) Adra2a, and (O) Tm4sf4 mRNA transcript levels were determined at 
e13.5, e15.5, and e18.5 and all genes compared wild type (grey bars) and Nkx2.2-/- pancreata (black bars). In situ hybridization 
comparing wild type and Nkx2.2-/- pancreas at e12.5, e14.5, and e17.5 of Tmem27 (B, C, D, G, H, and I), e14.5 of Adra2a (M 
and N), and e12.5, e14.5, and e17.5 of Tm4sf4 (P, Q, R, U, V, and W). Error bars represent SEM and asterisks denote statistical 
significance < 0.05. To assess co-expression, immunofluoresence staining of Tmem27 (E and J;green) and Ghrelin (F and K;cop-
per) was performed on adjacent sections. Similarly, adjacent sections to the Tm4sf4 in situ hybridizations were stained for ghre-
lin (T and Y;green) and overlayed (T and Y: inset 2× zoom). DAPI (blue) indicates nuclei. Magnification 20× for e12.5, e14.5, R, 
S, T, W, X, Y, while 40× for E, F, J, and K. Large black dashed lines outline the pancreas at e12.5 and e14.5. Small solid white 
lines outline Tmem27 and ghrelin co-expression areas. Dashed white lines outline Tmem27+ cells that do not co-express ghre-
lin.BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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in the pancreatic progenitors that give rise to all the pan-
creatic cell types. It is therefore possible that Nkx2.2 plays
a transient role in exocrine gene regulation. Whether these
gene expression changes translate into functional defects
cannot be determined in the Nkx2.2-/- animals, which die
shortly after birth.
Elastase 1 (Ela1) is a digestive enzyme produced within
the pancreatic acini [74,75]. In the Nkx2.2-/- pancreata,
Ela1 appears to be upregulated as early as e13.5 when
both exocrine and endocrine cell types are differentiating,
but prior to acini maturation (Table 2). We confirmed ele-
vated mRNA expression at e13.5 and e15.5 by qRTPCR
(Figure 4A) and demonstrated that the elevated Ela1 was
restricted to the exocrine compartment at e14.5 and e15.5
using mRNA in situ hybridization and immunofluores-
cence analysis (Figure 4B-E, I and 4L). It therefore appears
that there may be an increase in elastase expression per
cell, rather than ectopic expression of elastase.
Nephrocan (Nepn), a secreted glycoprotein of the kidney
that can inhibit TGFβ signaling and is important for a vari-
ety of essential developmental events including epithelial
to mesenchymal transitions (EMT) and cell migration
[76], also displays increased expression in the Nkx2.2-/-
pancreas at e12.5, e13.5, e14.5, and e15.5 (Table 2, Figure
4F, G, H, J, and 4K). Nepn has not been previously
reported in the pancreas, however, in both wild type and
Nkx2.2-/- pancreas, Nepn expression is detectable in the
exocrine compartment and overlaps with the elastase
expression domain (Figure 4H, I, K, and 4L). In the
embryonic kidney, Nepn is expressed transiently, with its
highest expression levels peaking at e11.5 [76]. Similarly,
in the Nkx2.2-/- pancreas, we could detect a large increase
in Nepn expression between e13.5 and e15.5, but by
e18.5 Nepn expression could not be detected by either
qRTPCR or mRNA in situ analysis (Figure 4F, G, H, J, K,
and data not shown). Furthermore, in both wild type and
Nkx2.2-/- pancreas Nepn mRNA expression was already
considerably lower at e15.5 when compared to e13.5,
although even at e15.5, Nepn levels were still significantly
higher in the mutant pancreas compared to wild type (Fig-
ure 4F; note y-axis scale). This would suggest that Nepn is
transiently upregulated in the exocrine pancreas of the
Nkx2.2-/- mice.
The exocrine gene serine protease inhibitor Kazal type 3
(Spink3) [77-79] is also affected in Nkx2.2-/- pancreata,
but unlike Ela1 and Nepn, Spink3 is downregulated in the
Nkx2.2-/- pancreas at e12.5 (Table 1). In wild type pan-
creas, Spink3 mRNA can be detected as early as e11.5 and
is expressed in acini by e13.5 continuing through e18.5.
Spink3 is also expressed in the intestine, kidney, and some
reproductive tissues during embryogenesis [77]. Recent
functional analysis suggests that Spink3 has essential roles
in the maintenance of the integrity and regeneration of
acinar cells. qRTPCR and in situ hybridization of Spink3
mRNA levels in the Nkx2.2-/-  pancreas confirmed the
downregulation of Spink3 at e12.5 (Figure 4M, N, and
4P) and e13.5 (Figure 4M). Spink3 mRNA levels in wild
type and Nkx2.2 null pancreata appear to equilibrate
between e15.5 and e18.5 (Figure 4M, O, and 4Q), suggest-
ing that the upregulation of Spink3 is a transient event.
A number of additional known exocrine genes are also
downregulated in the Nkx2.2-/- mice at e12.5, including
pancreatic lipase-related protein, chymotrypsinogen B1
and carboxypeptidase 2 (Table 1). There are no overt
changes in the number of exocrine cells or their morphol-
ogy and polarity in the Nkx2.2-/- mice to suggest a defect
in the formation of the exocrine cell population [19]. Fur-
thermore, Nkx2.2 expression normally becomes extin-
guished in the differentiated acini cells. We predict that
the observed exocrine gene expression changes reflect dif-
ferences in the regulation of these genes in the pancreatic
progenitor population. It is possible that these gene
expression changes are transient (as in the case of Nepn
and Spink3) or, alternatively, they may initiate events that
lead to persistent functional changes in the acini that are
as yet uncharacterized.
Conclusion
Although the Nkx2.2-/- mice display a severe islet cell mis-
specification phenotype, our microarray studies identified
very few altered transcription factor changes that contrib-
ute to these changes during the secondary transition.
What the global gene expression profiling suggests, how-
ever, is that Nkx2.2 plays a predominant role in regulating
islet cell fate choices within the Ngn3 regulatory circuit.
Nkx2.2 is not likely to function upstream of this regula-
tory junction, since the loss of Nkx2.2 does not affect the
expression of Pdx1, Ptfl1a or Sox9 (Figure 1 and data not
shown). We do, however, demonstrate that Ngn3 and its
functional partners, Myt1 and NeuroD1, all have reduced
expression in Nkx2.2-/- mice. The reduction of Myt1 and
NeuroD1 may be secondary to the reduction of Ngn3;
however, there are several lines of evidence to suggest that
the regulatory and functional inter-relationships between
these proteins are more complex, as summarized in Figure
5. It has been demonstrated that Nkx2.2 expression is
reduced in Ngn3-/- mice indicating that these proteins
function in a feedback loop [5]. Furthermore, Myt1
expression is decreased in Ngn3-/- mice, but Myt1 has also
been shown to induce Ngn3 activation, and Myt1 and
Ngn3 apparently cooperate in their regulation of islet dif-
ferentiation [40,41]. Additional studies have demon-
strated that ectopic expression of NeuroD1 activates
Nkx2.2 and it has been suggested that Ngn3 and Nkx2.2
autoregulate their own transcription [80]. These complex
regulatory interactions are likely necessary to fine tuneBMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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Loss of Nkx2.2 affects expression of known exocrine factors, Ela1, Spink3, and a novel secreted proteoglycan, Nepn Figure 4
Loss of Nkx2.2 affects expression of known exocrine factors, Ela1, Spink3, and a novel secreted proteoglycan, 
Nepn. qRTPCR of (A) Ela1 mRNA was assessed at e12.5, e13.5, and e15.5, (F) Nepn mRNA was assessed at e13.5 and e15.5, 
and (M) Spink3 mRNA transcript levels were determined at e12.5 and e13.5, while all gene expression analyses compared wild 
type (grey bars) and Nkx2.2-/- pancreata (black bars). In situ hybridization comparing wild type and Nkx2.2-/- pancreas at e14.5 
and e15.5 for Ela1 (B, C, D, and E), e12.5 and e14.5 for Nepn (G, H, J, and K), e12.5 and e15.5 for Spink3 (N, O, P, and Q). To 
show co-expression of Nepn in the exocrine compartment and confirm increased protein levels, Ela1 immunofluorescence was 
performed on adjacent sections (I and L;green). DAPI (C and E; blue) indicates nuclei. Error bars represent SEM and asterisks 
denote statistical significance < 0.05. Magnification 20×. Large dashed lines outline the pancreas at e12.5, e14.5, and e15.5. Small 
dashed lines outline areas of Nepn and Ela1 co-expression.BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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this critical juncture in islet cell specification. Precise reg-
ulation of the expression levels and activity of each of
these essential factors may be necessary for the appropri-
ate initiation of the critical developmental events that
function downstream of the Ngn3 progenitor, including
the regulation and co-regulation of downstream targets,
such as MafB, Isl1 and Etv1. Rather than the simple linear
regulatory pathway that is often invoked, an intricate web
of feedback and feedforward regulation must be necessary
to induce appropriate islet cell specification.
In this study, we have identified several known and novel
secreted and transmembrane proteins that may function
downstream of Nkx2.2 to mediate differentiation events.
Transmembrane proteins such as Tm4sf4 or signaling
molecules such as nephrocan may function in or on the
endocrine progenitor cells to translate the cell's intrinsic
signals to the environment or vice versa. The identifica-
tion and characterization of transmembrane and secreted
molecules that influence islet cell formation will provide
critical information about the extrinsic signals that are
necessary to manipulate pancreatic development and cell
differentiation. In support of this, a recent study demon-
strated the tetraspanin Tm4sf3 mediates fusion of the dor-
sal and ventral buds, as well as acinar cell differentiation
during Xenopus pancreatic development [81].
Finally, these studies demonstrate for the first time that
Nkx2.2 indirectly or directly regulates the expression of
several exocrine genes. The functional impact caused by
misregulation of these exocrine genes is not clear; how-
ever, it suggests that Nkx2.2 also plays a minor role in
non-endocrine lineages. It is possible that the regulation
of exocrine gene expression occurs in the "Nkx2.2 low"
expressing cells that are present in the Pdx1+, Ngn3- pan-
creatic progenitors [5]. This is similar to the finding that
deletion of Nkx6.1, a β cell transcription factor that is co-
expressed with Nkx2.2 in the early pancreatic epithelium,
transiently upregulates the expression of the exocrine fac-
tor Nkx6.2 in Pdx1+ pancreatic progenitor cells [82]. Mis-
regulation of additional exocrine genes was not reported
in the Henseleit study. However, we have determined that
Nkx6.2 is also upregulated in the Nkx2.2-/- pancreas (data
not shown; note: Nkx6.2 was not present on
PancChip6.1).
In summary, the results of our comparative expression
analysis of Nkx2.2-/- and wild type pancreata begins to
illustrate the cell type specific requirements for Nkx2.2 in
the regulation of endocrine and exocrine gene expression
and will ultimately help to dissect out the molecular func-
tions of Nkx2.2 in regulating important pancreatic cell
fate decisions.
Methods
Mice
Nkx2.2+/- heterozygous mice were previously generated by
homologous recombination [19] and were maintained on
a Swiss Black (Taconic) background. Genotyping of mice
and embryos was performed by PCR analysis as previ-
ously described [19,42]. Mice were housed and treated
according to Columbia University and UCDHSC IACUC
approval protocols.
RNA isolation
Nkx2.2+/- heterozygous males and females were mated
and plugged in order to know specific embryonic stage.
An n = 5 for e12.5 and e13.5 pancreata was collected for
each experimental group (wt and Nkx2.2-/-). Pancreata
were dissected from embryos and stored in RNAlater
(Ambion/ABI, TX) at 4°C until genotyping could be com-
pleted. Once genotyped, two pancreata were pooled for
each e12.5 experimental group and the following num-
bers of wild type and Nkx2.2-/- pancreata were pooled for
e13.5 experimental groups: n1 = 5wt, 6ko; n2 = 4wt, 5ko;
n3 = 4wt, 7ko; n4 = 4wt, 6ko; n5 = 3wt, 3ko. For each
pooled set, RNA was isolated using an RNeasy Micro Kit
(Qiagen, CA) without the DNase incubation step. The
concentration of the RNA samples was determined using
the NanoDrop®  ND-1000 UV-Vis Spectrophotometer.
RNA samples were analyzed using an Agilent 2100 Bioan-
alyzer Lab-On-A-Chip Agilent 6000 Series II chip to deter-
mine the integrity of the samples. The RNA was of high
quality with an RNA integrity number > 8.
A proposed model for an Nkx2.2 role during endocrine cell  specification at the secondary transition Figure 5
A proposed model for an Nkx2.2 role during endo-
crine cell specification at the secondary transition. 
The solid arrows indicate direct activation that is based on 
published regulatory data, while dashed arrows represent 
untested direct regulatory interactions proposed here as 
well as by other groups and in some cases known indirect 
regulation.BMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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RNA Amplification, Labeling, and Hybridization
For e12.5 RNA, approximately 200 ng of total RNA was
amplified using the MessageAmpTM II aRNA Amplifica-
tion Kit (Ambion/ABI, TX). After amplification 2.5 μg of
aRNA was indirectly labeled using amino-allyl dUTP and
anchored oligo(d)T prime reverse transcription. For e13.5
RNA, approximately 50 ng of total RNA was amplified
using the Ovation™ Aminoallyl RNA Amplification and
Labeling System (Nugen Inc, CA). The amplification proc-
ess resulted in a yield of 6-10 μg of amplified cDNA,
which was purified using the QIAquick PCR Purification
Kit (Qiagen, CA) and then eluted in coupling buffer (0.1
M Sodium Bicarbonate, pH 9). 2 μg of each cDNA was
coupled with the appropriate Cy3 or Cy5 fluorescent label
(Cy™ Dye, Amersham Pharmacia Biotech Ltd, NJ), com-
bined and purified using the MinElute PCR Purification
Kit (Qiagen, CA). After coupling, the Cy3 and Cy5 sam-
ples were combined and purified using the MinElute PCR
Purification Kit (Qiagen, CA). After purification, 2.5 μg of
Mouse Cot1 DNA (Invitrogen Life Technologies) and 2.5
μg Oligo-dT were added to each sample and denatured at
95°C for 5 min. The samples were then cooled to 42°C
and an equal volume of 2× hybridization buffer (50% for-
mamide, 10× SSC, and 0.2% SDS) was added, mixed, and
applied to the Mouse PancChip 6.1 cDNA microarray
slide.
Microarray
The Mouse PancChip 6 contains 13,059 mouse cDNAs
chosen for their expression in various stages of pancreatic
development, many of which are not found on commer-
cially available arrays [83]. Stringent quality control meas-
ures resulted in the sequence verification of all probes on
the array. The results are presented as downloadable gene
lists, available at: https://www.cbil.upenn.edu/
RADQuerier/php/displayStudy.php?study_id=3061
Scanning and Image Analysis
Microarray slides were hybridized overnight, then washed
and scanned with an Agilent G2565BA Microarray Scan-
ner. Images were analyzed with GenePix 5.0 software
(Axon Instruments). Median foreground intensities were
obtained for each spot and imported into the mathemati-
cal software package "R", which was used for all data
input, diagnostic plots, normalization and quality check-
ing steps of the analysis process using scripts developed
in-house by PW. The ratio of expression for each element
on the array was calculated in terms of M (log2(Red/
Green)) and A ((log2(Red) + log2(Green))/2)). The data-
set was filtered to remove positive control elements (Cy3
anchors and SpotReport elements) and any elements that
had been manually flagged as bad. The M values were
then normalized by the print tip loess method using the
"marray" microarray processing package in "R". Statistical
analysis was performed in "R" using both the LIMMA and
SAM packages. For the e12.5 study, 4 out of the 5 hybrid-
izations passed quality control specifications and were
subsequently used for analysis. For the e13.5 study all 5
hybridizations were analyzed.
Quantitative Real-Time PCR
Total RNA was harvested from e12.5, e13.5, e15.5, and
e18.5 whole pancreata using the RNeasy Micro or Mini Kit
(Qiagen). Experimental n = 3 for each embryonic age. For
each age group 1 μg total RNA was converted to cDNA
using the Superscript III Kit (Invitrogen). qRTPCR was
performed using custom primers and SYBR green
(Applied Biosystems) or Taqman (Applied Biosystems)
primer and probe sets. Refer to Additional File 3: Table S2
for all primer/probe sets used. Gene of interest relative
mRNA expression levels were determined by using the
standard curve method (User Bulletin #2, ABI Prism 7700
Sequence Detection System, Applied Biosystems) for each
sample and was subsequently normalized to relative
Cyclophilin B mRNA levels. All qRTPCR single-plex reac-
tions were performed on an ABI PRISM 7000 Sequence
Detection System.
In situ hybridization
RNA in situ hybridization was performed as previously
described [34] on e12.5, e14.5, and e17.5 whole embryo
frozen 8 μm sections that were fixed overnight with 4%
paraformaldehyde. The following cDNA clones were
ordered from Open Biosystems: Adra2a (EMM1002-
22629), Ela1 (MMM1013-65444), MafB (MMM1013-
7514203), Myt1 (MMM1013-9334659), Spink3
(EMM1002-6296766), Tmem27 (MMM1013-9200171),
Tm4sf4 (MMM1013-65619). Nepn cDNA was cloned
from isolated kidney total RNA with the following prim-
ers: forward 5'-GCAATGCACCCGCTTTGGGCTTTTC,
reverse 5'-ATCTATTTCATAATCGTCATCGTCGTC. The
cDNA clones encoding full-length Nkx2.2 and Ngn3 were
described previously [19,84]. cDNA plasmids were linear-
ized and in situ antisense probes were transcribed with the
following restriction enzymes and polymerases: Adra2a
(EcoRI, T7), Ela1 (EcoRI, T7), MafB (EcoRI, T7), Myt1
(SalI, T3), Nepn (XhoI, Sp6), Ngn3 (BamHI, T7), Nkx2.2
(NotI, T7), Spink3 (EcoRI, Sp6), Tmem27 (EcoRI, T7),
and Tm4sf4 (SmaI, T7). Sense probes were also tested for
each gene without any evidence of non-specific staining.
In situ hybridizations were performed on wild type and
Nkx2.2-/- littermate embryos. Pictures were acquired on a
Leica CTR 5000 with 20× magnification.
Immunofluorescence
Immunofluorescence was performed on e12.5, e14.5, and
e17.5 whole embryo frozen 8 μm sections that were fixed
overnight with 4% paraformaldehyde. Rabbit α-Elastase1
antibody (Abcam, ab21593) was used at 1:1000. Rabbit
α-ghrelin (Phoenix Pharmaceuticals, CA) was used atBMC Developmental Biology 2009, 9:65 http://www.biomedcentral.com/1471-213X/9/65
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1:200. Rabbit α-Tmem27 (M. Stoffel, ETH Zurich) was
used at 1:200. Rabbit a-MafB (Bethyl Laboratories, TX)
was used at 1:1000. Donkey a-rabbit-Cy5 or α-rabbit-Cy2
(Jackson ImmunoResearch, PA) were used at 1:300. DAPI
(Invitrogen, CA) was used at 1:1000 and incubated for 30
min. Confocal images were taken on a Zeiss META LSM
510.
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